MYO1H and small cell lung carcinoma: Highly expressed MYO1H was mainly enriched in linoleic acid metabolism, metabolism of xenobiotics by cytochrome P450, and retinol metabolism, while lowly expressed MYO1H was mainly enriched in glycosaminoglycan biosynthesis chondroitin sulfate, P53 signaling pathway, and small cell lung cancer.